Results for tag: "Foralumab"

Formalumab is a monoclonal antibody used to treat immune disorders. It is a type of immunotherapy, which works by targeting and blocking certain proteins that are involved in the body's immune response. Formalumab is used to treat a variety of immune-related conditions, including rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. It is also used to treat certain types of cancer, such as non-Hodgkin's lymphoma and multiple myeloma. Formalumab is administered intravenously, and is usually given in combination with other medications. Formalumab is a relatively new drug, and is still in the early stages of development. It is not yet widely available, and is only approved for use in certain countries. However, it is expected to become more widely available in the near future. Some companies in the Formalumab market include AbbVie, Amgen, Bristol-Myers Squibb, and Merck. Show Less Read more